cerebrovascular disease

Related by string. cerebrovascular diseases * Cerebrovascular . cerebro vascular : cerebrovascular . cerebrovascular events . cerebrovascular accident . cerebrovascular surgery . Cerebrovascular Disease / diseases . Disease . Diseases . DISEASE . DISEASES : Treat Diseases Inc. . mad cow disease . Disease Control . heart disease * cardiovascular disease cerebrovascular disease *

Related by context. All words. (Click for frequent words.) 66 cerebral infarction 64 cerebrovascular diseases 64 autonomic dysfunction 63 CVD mortality 62 cerebral vascular disease 62 atherosclerotic disease 62 cardiovascular disease hypertension 61 thrombotic events 61 atherothrombotic disease 61 myocardial infarction stroke 61 colorectal adenoma 61 de ath 60 atherosclerotic cardiovascular disease 60 macrovascular events 60 CHD CVD 60 HF hospitalization 60 infarctions 60 myocardial infarction MI 60 nonfatal MI 60 silent ischemia 60 cardiovascular disease 59 cerebrovascular 59 nonfatal myocardial infarction MI 59 LV dysfunction 59 coronary heart 59 coronary disease 59 gallstone disease 59 cardiovascular mortality 59 nonischemic 59 cerebral infarctions 59 hyperglycaemia 59 cerebrovascular accident 59 thromboembolism 59 cerebrovascular events 59 elevated triglyceride levels 58 hemorrhagic strokes 58 microbleeds 58 valvular disease 58 abnormal lipids 58 decompensated heart failure 58 recurrent ischemia 58 subclinical hyperthyroidism 58 nonfatal stroke 58 systolic dysfunction 58 atherothrombosis 58 Vascular dementia 58 Erythropoietic therapies may 58 nonfasting triglycerides 58 cardioembolic stroke 58 neurological abnormalities 58 haemorrhagic stroke 58 cerebral vascular 58 noncardiovascular mortality 58 renal insufficiency 58 nonfasting triglyceride levels 57 acute myocardial infarctions 57 impaired glucose metabolism 57 beta blockers ACE inhibitors 57 carotid stenosis 57 angina chest 57 lipid lowering agents 57 thyrotropin levels 57 myocardial infarctions 57 Aortic stenosis 57 systolic hypertension 57 ischemic cardiomyopathy 57 myocardial ischemia 57 nonfatal myocardial infarction 57 acute myocardial infarction AMI 57 ischemic heart 57 thromboembolic 57 β blocker 57 unstable angina pectoris 57 hypertension diabetes mellitus 57 vascular cognitive impairment 57 coronary revascularization procedures 57 subclinical atherosclerosis 57 cryptogenic stroke 57 arterial calcification 57 neurologic complications 57 subclinical hypothyroidism 57 rhythm disturbances 57 myocardial infarction 57 nondiabetic patients 57 noncardiac 57 coronary artery disease 57 distal colon cancer 57 unknown etiology 57 primary aldosteronism 57 COPD exacerbation 57 malignant neoplasm 57 valvular heart disease 57 left ventricular hypertrophy 56 microvascular complications 56 cerebrovascular accidents 56 left ventricular dysfunction 56 microvascular disease 56 carotid artery blockage 56 symptomatic intracranial 56 ejection fractions 56 colorectal adenomas 56 Coronary artery calcification 56 cardiomyopathies 56 hypertension 56 recurrent wheezing 56 preserved ejection fraction 56 β blockers 56 ischemic strokes 56 carotid atherosclerosis 56 carotid IMT 56 peripheral arterial occlusive disease 56 Ischemic stroke 56 highest quintile 56 hypercoagulable 56 revascularisation procedures 56 heart disease 56 fatal myocardial infarction 56 diabetic kidney 56 diabetes mellitus hypertension 56 cardio vascular disease 56 noncardiovascular 56 coronary calcification 56 metabolic abnormalities 56 revascularization procedures 56 diastolic blood pressures 56 cardiovascular diseases 56 fatal IHD 56 diabetic microvascular complications 56 Sleep disturbances 56 underwent coronary angiography 56 nontraumatic 56 intracranial atherosclerosis 56 hemorrhagic stroke 56 unstable angina 56 hyperkalemia 56 recurrent coronary 56 cerebral embolism 56 postoperative AF 56 interstitial lung diseases 56 ipsilateral stroke 56 reinfarction 56 intracerebral hemorrhage 56 hypertension dyslipidemia 56 advanced adenoma 56 intracerebral haemorrhage 56 syncopal 56 progressive dyspnea 56 fasting glucose levels 56 Uncontrolled hypertension 56 Myocardial infarction 56 MMSE scores 56 repeat revascularization 56 arterial thromboembolic events 56 postoperative pulmonary 56 carotid bruit 56 chronic thromboembolic pulmonary 56 ischemic vascular 55 hemorrhagic bleeding 55 white matter hyperintensities 55 extrapyramidal symptoms 55 underwent CABG 55 atherogenic dyslipidemia 55 empyema 55 alcoholic liver 55 PLX STROKE targeting 55 inflammatory rheumatic 55 cardiac dysfunction 55 NSTEMI 55 albumin excretion 55 obstructive coronary 55 urolithiasis 55 renal dysfunction 55 occlusive disease 55 recurrent DVT 55 HIV HCV coinfected 55 recurrent myocardial infarction 55 Coronary artery disease 55 intima media thickness 55 variant angina 55 circulatory diseases 55 untreated sleep apnea 55 #mm Hg 55 isolated systolic hypertension 55 Dilated cardiomyopathy 55 IPAH 55 ATACAND 55 macrovascular disease 55 infarction NSTEMI 55 albuminuria 55 NYHA Class II 55 artery occlusion 55 hepatorenal syndrome 55 impaired cognition 55 CTEPH 55 post thrombotic syndrome 55 coronary atherosclerosis 55 acute coronary 55 dyslipidaemia 55 pharyngeal cancer 55 Ischemic strokes 55 recurrent VTE 55 non valvular atrial 55 proliferative retinopathy 55 comorbid depression 55 CHD mortality 55 pulmonary embolism PE 55 thyrotoxicosis 55 cardiovascular hospitalization 55 MACCE 55 ischemic stroke 55 artery stenosis 55 cerebral thrombosis 55 nonmelanoma skin cancer 55 vascular disease 55 embolic stroke 55 resuscitated cardiac arrest 55 TEAEs 55 atrophic gastritis 55 Hemorrhagic stroke 55 glycated hemoglobin levels 55 uncontrolled hypertension 55 postoperative mortality 55 amenorrhoea 55 highest tertile 55 hypertension hypercholesterolemia 55 cardiac insufficiency 55 nonmelanoma skin cancers 55 vasculopathy 55 definite stent thrombosis 55 obstructive coronary artery 55 arteriography 55 hyperhomocysteinemia 55 dysglycemia 55 myocardial ischaemia 55 infarcts 55 cardiovascular hospitalizations 55 hemorrhagic complications 55 asymptomatic PAD 55 ischemic complications 55 atherothrombotic 55 cardioembolic 55 hypoxemia 55 unstable angina chest 55 anticoagulants blood thinners 54 nonfatal heart 54 Ischemic heart 54 silent myocardial ischemia 54 hippocampal atrophy 54 nonalcoholic steatohepatitis 54 Pulmonary hypertension 54 dopaminergic therapy 54 metabolic acidosis 54 thrombocytopenic 54 undergoing coronary artery 54 macrovascular complications 54 cirrhosis liver failure 54 symptomatic VTE 54 patients undergoing CABG 54 angiotensin II receptor blockers 54 haemorrhagic strokes 54 Arrhythmogenic Right Ventricular Cardiomyopathy 54 cytopenias 54 homocysteine concentrations 54 Sleep disordered breathing 54 diabetes mellitus 54 hypercholesterolemia 54 parkinsonism 54 postoperative delirium 54 carotid plaque 54 etiologic 54 hypercalcaemia 54 postoperative complications 54 acute myocardial infarction MI 54 cerebral microbleeds 54 nonvertebral fractures 54 systemic embolism 54 Atrial fibrillation AF 54 pericardial effusions 54 acute coronary syndromes 54 NYHA functional class 54 Postoperative complications 54 atherosclerotic vascular disease 54 pericardial effusion 54 MetS 54 intracerebral hemorrhages 54 neurologic symptoms 54 thiazide diuretic 54 pulmonary capillary wedge 54 carotid plaques 54 interstitial pneumonitis 54 serum PTH 54 FluCAM arm 54 Alzheimer disease vascular dementia 54 multi infarct dementia 54 chronic renal insufficiency 54 lower extremity amputations 54 cardio respiratory fitness 54 microalbuminuria 54 prostate carcinogenesis 54 rheumatoid factor 54 upper gastrointestinal bleeding 54 perioperative mortality 54 elevated LDL cholesterol 54 predisposing factor 54 autoimmune thyroid 54 thromboses 54 familial pancreatic cancer 54 elevated LDH 54 postoperative complication 54 ventricular arrhythmia 54 CP CPPS 54 DVT PE 54 KIF6 carriers 54 urgent coronary revascularization 54 perioperative morbidity 54 variceal bleeding 54 microangiopathy 54 angiotensin converting enzyme inhibitors 54 liver cirrhosis 54 loop diuretics 54 acute coronary syndrome 54 perioperative complications 54 overt nephropathy 54 coronary revascularizations 54 comorbidities 54 NAFLD 54 intracranial stenosis 54 cardiopulmonary diseases 54 spontaneous bacterial peritonitis 54 Relapsing remitting MS 54 obstructive pulmonary disease 54 elevated fasting glucose 54 Excessive daytime sleepiness 54 Renal impairment 54 optic neuropathy 53 prolonged QT interval 53 aneurysmal subarachnoid hemorrhage 53 Critical limb ischemia 53 cardiovascular morbidity 53 aortic stiffness 53 hsCRP 53 Hypertrophic cardiomyopathy 53 Venous thromboembolism 53 aldosterone antagonist 53 hepatic cirrhosis 53 symptomatic intracerebral hemorrhage 53 insulin resistance syndrome 53 histologic subtype 53 nondiabetics 53 hypokalemia hypomagnesemia 53 thromboembolic complications 53 serum estradiol 53 non aspirin NSAIDs 53 angina pectoris 53 arterial thickening 53 sustained ventricular tachycardia 53 rs# [002] 53 cerebro vascular 53 inflammatory biomarkers 53 acute myocardial infarction 53 rebleeding 53 hypoperfusion 53 chronic metabolic acidosis 53 Daytime sleepiness 53 arterial hypertension 53 ABCB1 53 onset diabetes mellitus 53 mmHg diastolic 53 temporal arteritis 53 thickness IMT 53 prostate cancer CaP 53 Acute coronary syndromes 53 antiplatelet drugs 53 obesity insulin resistance 53 Peripheral arterial disease 53 postural hypotension 53 thyroid dysfunction 53 LVSD 53 renal disease 53 diastolic pressures 53 Diabetic neuropathy 53 hepatic failure 53 pulmonary thromboembolism 53 neuropsychiatric symptoms 53 cardiovascular disease CVD 53 hypophosphatemia 53 elevated triglycerides 53 nonfatal cardiovascular 53 shorter telomere length 53 TT genotype 53 serum selenium 53 inhospital 53 anticholinergic medications 53 diabetes hyperlipidemia 53 stroke transient ischemic 53 PRADAXA #mg 53 recurrent tonsillitis 53 multivariate adjustment 53 angiotensin receptor blockers ARBs 53 VaD 53 Prehypertension 53 comorbid illnesses 53 eplerenone 53 Eisenmenger syndrome 53 angiotensin converting enzyme inhibitor 53 coronary intervention 53 asplenia 53 chronic periodontitis 53 cerebral oxygenation 53 GI bleeding 53 myocardial infarctions MIs 53 acute coronary syndromes ACS 53 severe exacerbations 53 kidney dysfunction 53 metabolic syndrome MetS 53 emphysema chronic bronchitis 53 venous thrombotic events 53 lacunar 53 left ventricular systolic 53 asymptomatic carotid stenosis 53 Myocardial Infarction MI 53 chorioamnionitis 53 torsades de pointes 53 elevated homocysteine 53 diastolic BP 53 hereditary predisposition 53 OSAHS 53 Pulmonary embolism 53 vascular dysfunction 53 congential 53 undergoing coronary angiography 53 thrombo embolic 53 Hemorrhagic strokes 53 SRBD 53 angioplasties stents 53 gastrointestinal hemorrhage 53 Thiazolidinediones 53 chronic bronchitis emphysema 53 pathophysiologic 53 e4 allele 53 APOE gene 53 coronary stenosis 53 chronic obstructive 53 potentially modifiable 53 chronic obstructive lung 53 multivessel disease 53 neurodevelopmental impairment 53 potassium sparing diuretics 53 Diabetic nephropathy 52 laryngeal cancer 52 infarction STEMI 52 coronary revascularization 52 glycosylated hemoglobin HbA1c 52 gallbladder disease 52 nadolol 52 smoldering myeloma 52 incomplete revascularization 52 events MACE 52 serum triglycerides 52 lupus erythematosus 52 colorectal carcinoma 52 aspirin clopidogrel 52 Asymptomatic 52 tachyarrhythmias 52 congenital abnormalities 52 acute decompensation 52 rhythm abnormality 52 noncardiac surgery 52 atherosclerosis narrowing 52 affective psychoses 52 myocardial infarction ventricular fibrillation 52 macroalbuminuria 52 SIDS infants 52 Coronary heart 52 colorectal neoplasia 52 transferrin saturation 52 Pulmonary arterial hypertension 52 postoperative atrial fibrillation 52 torsade de pointes 52 pyelonephritis 52 peptic ulcer 52 Wernicke Korsakoff syndrome 52 cilostazol 52 hypopneas 52 subtrochanteric 52 familial adenomatous polyposis 52 cardiomegaly 52 Breteler 52 unprovoked seizures 52 neurological complications 52 asthma emphysema bronchitis 52 granulomatous 52 metabolic abnormality 52 hyperlipidaemia 52 ARVD 52 thromboembolic events 52 claudication 52 bacterial prostatitis 52 tHcy 52 thrombotic complications 52 Gastric cancer 52 Idiopathic pulmonary fibrosis 52 ALI ARDS 52 HeFH 52 comorbid conditions 52 familial hypercholesterolemia 52 elevated CRP 52 coronary thrombosis 52 MGUS 52 lipid lowering medication 52 pyrexia mucositis sepsis febrile 52 VT VF 52 atherosclerotic cardiovascular 52 asthma bronchitis emphysema 52 deep vein thromboses 52 beta blocker therapy 52 bypass graft CABG surgery 52 myocardial fibrosis 52 progressive neurodegenerative disorder 52 Diabetes mellitus 52 chronic hepatitis cirrhosis 52 neurologic diseases 52 Cognitive impairment 52 advanced adenomas 52 psychiatric comorbidities 52 induce orthostatic hypotension 52 serum creatinine levels 52 idiopathic pulmonary arterial hypertension 52 nonalcoholic steatohepatitis NASH 52 diabetes dyslipidemia 52 NYHA class 52 inhaled glucocorticoids 52 fibrosis scarring 52 nonobstructive CAD 52 carotid artery thickness 52 serous ovarian cancer 52 pulmonary dysfunction 52 atherosclerotic coronary 52 APOE e4 52 atherosclerosis 52 angiotensin receptor blockers 52 ADPKD 52 vascular inflammation 52 interstitial pneumonia 52 ischemic cerebrovascular 52 plasma homocysteine 52 ruptured aneurysms 52 venous thrombosis 52 arteries atherosclerosis 52 long QT syndrome 52 superficial vein thrombosis 52 subarachnoid hemorrhages 52 treat brain aneurysms 52 platelet activation 52 PAOD 52 Obstructive sleep apnea 52 lupus scleroderma 52 infarction 52 amnestic mild cognitive impairment 52 carotid artery narrowing 52 cardiovascular 52 recurrent venous thromboembolism 52 polymorphic ventricular tachycardia 52 distant metastasis 52 hypovitaminosis D 52 arterial stiffening 52 bicuspid aortic valves 52 esophageal reflux 52 proliferative diabetic retinopathy 52 artery calcification 52 degenerative disorders 52 MMSE score 52 dyslipidemia hypertension 52 PNH patients 52 T1DM 52 Ischemic 52 esophagitis 52 myocardial infraction 52 nonischemic cardiomyopathy 52 H2 receptor antagonists 52 atherosclerotic 52 NHANES III 52 Renal dysfunction 52 diabetes mellitus DM 52 acid suppressive medications 52 depressive disorders 52 vascular dementia 52 dopamine antagonists 52 primary hyperparathyroidism 52 irbesartan 52 serum phosphate 52 gastrointestinal perforation 52 nonvertebral fracture 52 cirrhosis liver cancer 52 thrombolytic agents 52 venous thromboembolic disease 52 arteriosclerotic 52 de aths 52 afterload 52 recurrent stroke 52 periprocedural 52 #OHD levels 52 postoperative infections 52 benazepril 52 familial aggregation 52 intensive statin therapy 52 kidney insufficiency 52 prothrombotic 52 androgen deficiency 52 CHD coronary 52 postoperative morbidity 52 ST elevation myocardial 52 cerebrovascular ailments 52 Atherosclerotic 52 ticlopidine 52 serum calcium 52 perfusion defects 52 gastrointestinal bleeding 52 hypoglycaemic episodes 52 NNT = 52 elevated lipase 52 laryngeal cancers 52 calcium antagonists 52 antihypertensive medication 51 malignant neoplasms 51 contrast induced nephropathy 51 Peripheral artery disease 51 flavonoid intake 51 diastolic hypertension 51 venous thromboembolisms 51 hyperparathyroidism 51 hypopituitarism 51 comorbid anxiety 51 untreated celiac disease 51 cardiogenic pulmonary edema 51 serum uric acid 51 fractional shortening 51 lightheadedness fainting 51 mediastinitis 51 endometrial hyperplasia 51 stable angina 51 hypercholesterolaemia 51 psychiatric morbidity 51 pulmonary exacerbations 51 vasovagal syncope 51 Mitral regurgitation 51 cerebral vasospasm 51 psychiatric comorbidity 51 idiopathic PAH 51 carotid endarterectomy 51 lower extremity amputation 51 elevated serum creatinine 51 gestational diabetes mellitus 51 liver transplantations 51 Arrhythmias 51 candesartan 51 renal artery stenosis 51 platelet reactivity 51 refractory ischemia 51 arterial stiffness 51 abdominal adiposity 51 Subarachnoid hemorrhage 51 Subgroup analyzes 51 Vitamin B# deficiency 51 NATRECOR ® 51 latent celiac disease 51 thromboembolic disease 51 intermittent claudication 51 myocardial infarct 51 heterotaxy 51 plasma homocysteine levels 51 psoriatic arthritis PsA 51 HbA 1c levels 51 Orthostatic hypotension 51 squamous cell cancers 51 extrapulmonary 51 recurrent UTI 51 hypertension congestive heart 51 abnormal lipid 51 distensibility 51 peripheral artery 51 meningitis encephalitis 51 lipid lowering therapy 51 lumbar disk herniation 51 triglyceride concentration 51 TMP SMX 51 Major depressive disorder 51 hyperphenylalaninemia HPA due 51 chronic immune thrombocytopenic 51 SGPT 51 gastric cardia 51 aged ≥ 51 esophageal squamous cell carcinoma 51 valvular heart 51 myeloproliferative neoplasms 51 COPD emphysema 51 AAT deficiency 51 Knee osteoarthritis 51 bridging fibrosis 51 recurrent acute pancreatitis 51 keloid scarring treatment 51 syncope fainting 51 retinopathy nephropathy 51 P = .# 51 ANCA associated 51 thiazide 51 clinically meaningful reductions 51 chronic bronchitis asthma 51 reinterventions 51 pericardial mesothelioma 51 binary restenosis 51 severe hypoglycemic 51 neurocognitive deficits 51 vaso occlusive crisis 51 osteoporotic vertebral fractures 51 Proteinuria 51 spondyloarthritis 51 cTnT 51 comorbidity 51 Left ventricular hypertrophy 51 lipid lowering drugs 51 metabolic syndromes 51 mL/min/#.# m 2 51 acute myocarditis 51 cerebrovascular disorders 51 APOE ε4 51 Ectopia Cordis 51 Elevated CRP 51 pathophysiological mechanisms 51 multisystem disease 51 HNSCC 51 hematopoietic cancers 51 deep venous thromboses 51 lipid lowering medications 51 cryptorchidism 51 Untreated sleep apnea 51 intracerebral 51 Idiopathic 51 nasal polyposis 51 thrombophilia 51 apnea hypopnea index 51 pathologic fracture 51 transaminase elevations 51 immunodeficiencies 51 dermatologic reactions 51 vasodilators 51 cryptogenic 51 Torsades de Pointes 51 undergoing CABG 51 salmeterol HFA MDI 51 adenomatous polyps 51 sudden cardiac death 51 amyloid deposition 51 severe obstructive pulmonary 51 Hypertriglyceridemia 51 thiazide diuretics 51 Endothelial dysfunction 51 encephalitis meningitis 51 Stomach cancer 51 troponin T 51 ventricular remodeling 51 Hospitalizations 51 cerebral ischemia 51 monoclonal gammopathy 51 aortic valve stenosis 51 atrioventricular valve 51 gait disturbance 51 node metastases 51 hypercalciuria 51 hyperprolactinemia 51 venous thromboembolism 51 pulmonary exacerbation 51 mucosal inflammation 51 primidone 51 hyperlipemia 51 mm Hg systolic 51 nonaspirin 51 neurologic outcomes 51 nonmalignant 51 serum potassium 51 systemic autoimmune 51 vWD 51 Intracerebral hemorrhage 51 acid suppressive drugs 51 cystic fibrosis chronic pancreatitis 51 ischemic colitis 51 Buerger Disease 51 bifurcated lesions 51 postmenopausal hormone 51 rehospitalization 51 natriuresis 51 sleep apneas 51 Stent thrombosis 51 lumbar spinal stenosis 51 hay fever allergic rhinitis 51 anginal symptoms 51 onset atrial fibrillation 51 density lipoprotein cholesterol 51 tertiles 51 hip BMD 51 cardiac conduction 51 patients undergoing percutaneous 51 thrombophlebitis 51 angiographically 51 atherothrombotic events 51 Plaque buildup 51 oropharyngeal 51 antihypertensive medications 51 radiochemotherapy 51 poorer prognosis 51 coronary insufficiency 51 recurrent ischemic stroke 51 revascularizations 51 cognitively normal 51 CC genotype 51 periprocedural MI 51 Angiograms carry slight 51 flutamide 51 bleeding diathesis 51 thalassemia sickle cell 51 serum lipid levels 51 preserved systolic 51 epididymitis 51 Hb A1C 51 Cardio vascular 51 obstructive lung 51 interstitial lung abnormalities 51 percutaneous transluminal coronary angioplasty 50 neutropenia dehydration dyspnea 50 clinico pathological 50 mycophenolate mofetil 50 pulmonary embolus 50 oral hypoglycemic agents 50 pharyngeal cancers 50 obstructive CAD 50 biochemical recurrence 50 Oxidative stress 50 intracranial hemorrhage ICH 50 tolvaptan 50 inflammatory markers 50 gene APOE 50 proximal DVT 50 orchitis 50 acute ischemic 50 Genetic variants 50 severe hypoglycaemia 50 cognitive dysfunction 50 hydroxyvitamin D levels 50 radicular pain 50 non cirrhotic portal 50 liver transplant recipients 50 intra abdominal abscess 50 habitual snoring 50 Homocysteine levels 50 lichen planus 50 elevated IOP 50 baseline HbA1c 50 multivariable analysis 50 paclitaxel eluting stents 50 glomerular filtration rate 50 comorbid disorders 50 angina myocardial infarction 50 clinically detectable 50 precancerous colon polyps 50 NYHA Class III 50 STEMIs 50 sociodemographic characteristics 50 pulmonary emphysema 50 lowest tertile 50 normotensive 50 undergoing radical prostatectomy 50 Ramipril 50 precancerous cervical 50 acute respiratory tract infections 50 stroke myocardial infarction 50 serum calcium levels 50 esophageal varices 50 Severe hypoglycemia 50 infective endocarditis 50 diabetes cardiovascular disease 50 LV ejection fraction 50 invasive ductal 50 #mg/dL [001] 50 cytogenetic abnormalities 50 acutely decompensated congestive heart 50 reoperations 50 osteoarthritis rheumatoid arthritis 50 VTEs 50 arteriosclerosis 50 esophageal cancers 50 severe neutropenia 50 ventricular tachycardia VT 50 ruptured abdominal aortic 50 diabetes hypertension hyperlipidemia 50 ischemic cardiovascular 50 aldosterone antagonists 50 TAXUS p value 50 necrotizing pancreatitis 50 familial ALS 50 stenoses 50 antiplatelet medications 50 erythema nodosum 50 MYH9 gene 50 prognostic significance 50 neonatal morbidity 50 malperfusion 50 prefrontal regions 50 LRRK2 mutations 50 prednisone prednisolone 50 subclinical cardiovascular disease 50 sudden sensorineural hearing 50 coagulation abnormalities 50 metabolic disturbances 50 valsartan 50 fragility fractures 50 chronic HBV infection 50 aortic rupture 50 basal cell nevus syndrome 50 Ischaemic stroke 50 airflow obstruction 50 undergone radical prostatectomy 50 TNF antagonist 50 Framingham Offspring Study 50 salpingo oophorectomy 50 visceral adiposity 50 Shy Drager syndrome 50 Sezary syndrome 50 obstructive sleep 50 myocardial infarction congestive heart 50 coronary interventions 50 nicardipine 50 open angle glaucoma 50 adenomatous 50 hypoglycemic events 50 Severe Primary IGFD 50 COPD exacerbations 50 bronchial hyperresponsiveness 50 Hip fractures 50 haloperidol Haldol 50 interstitial lung disease 50 antihypertensive drugs 50 intracranial bleeding 50 clot formation 50 glitazones 50 pCR 50 candesartan cilexetil 50 thyrotropin 50 delayed gastric emptying 50 intracranial haemorrhage 50 cirrhosis scarring 50 GBA mutations 50 sCJD 50 unstable angina UA 50 vestibular dysfunction 50 Invasive pneumococcal disease 50 retinal vascular 50 Hp2 2 50 hepatocellular carcinomas 50 Autoimmune disorders 50 mechanically ventilated patients 50 coronary artery revascularization 50 diastolic dysfunction 50 beta blockers 50 candidemia 50 neuropathological 50 tumor lysis syndrome 50 vitamin D inadequacy 50 APOE e4 allele 50 atypical ductal hyperplasia 50 Cardiogenic shock 50 IDDM 50 afib 50 arterial thromboembolism 50 renal cell carcinomas 50 Heavy snorers 50 essential thrombocythemia 50 Alzheimer Disease AD 50 multivariable adjusted 50 Taxus Stent 50 silent brain infarcts 50 lipid disorders 50 symptom exacerbation 50 hemodynamically unstable 50 APOE genotype 50 intrathoracic 50 ACE inhibitors 50 dermopathy 50 SSc 50 nonarteritic anterior ischemic optic 50 LVEF 50 NIASPAN 50 hyperlipidemia hypertension 50 POAG 50 Chronic ITP 50 hyperacute 50 AML MDS 50 pneumonia sepsis 50 acute aortic dissection 50 untreated hypothyroidism

Back to home page